Sharon Townson

Insider Reports History

Entity
Individual
Location
Monte Rosa Therapeutics, Inc., 40 Guest Street, Boston, MA
Signature
/s/ Phil Nickson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sharon Townson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 40K Jun 3, 2024 Direct

Insider Reports Filed by Sharon Townson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Chief Scientific Officer
GLUE Monte Rosa Therapeutics, Inc. May 28, 2024 0 $0 3 Jun 5, 2024 Chief Scientific Officer
GLUE Monte Rosa Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 4, 2023 Chief Technology Officer
GLUE Monte Rosa Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 2, 2022 Chief Technology Officer
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 Chief Technology Officer